Aron Goldhirsch

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Rabaglio M; Sun Z; Price K N; Castiglione-Gertsch M; Hawle H; Thürlimann B; Mouridsen H; Campone M; Forbes J F; Paridaens R J; Colleoni M; Pienkowski T; Nogaret J-M; Láng I; Smith I; Gelber R D; Goldhirsch A; Coates A S;
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
Nolè Franco; Crivellari D; Mattioli R; Pinotti G; Foa P; Verri E; Fougeray R; Brandely M; Goldhirsch A
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Aron Goldhirsch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Breast cancer research and treatment 2009;118(2):385-94.
2009: Rabaglio M; Sun Z; Price K N; Castiglione-Gertsch M; Hawle H; Thürlimann B; Mouridsen H; Campone M; Forbes J F; Paridaens R J; Colleoni M; Pienkowski T; Nogaret J-M; Láng I; Smith I; Gelber R D; Goldhirsch A; Coates A S;
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(9):1489-98.
2009: Nolè Franco; Crivellari D; Mattioli R; Pinotti G; Foa P; Verri E; Fougeray R; Brandely M; Goldhirsch A
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 2009;64(4):673-80.
2009: Pagani Olivia; Price Karen N; Gelber Richard D; Castiglione-Gertsch Monica; Holmberg Stig B; Lindtner Jurij; Thürlimann Beat; Collins John; Fey Martin F; Coates Alan S; Goldhirsch Aron;
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Breast cancer research and treatment 2009;117(2):319-24.
2009: Viale Giuseppe; Rotmensz Nicole; Maisonneuve Patrick; Orvieto Enrico; Maiorano Eugenio; Galimberti Viviana; Luini Alberto; Colleoni Marco; Goldhirsch Aron; Coates Alan S
Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
Breast cancer research and treatment 2009;117(1):211-4.
2009: Mouridsen Henning; Giobbie-Hurder Anita; Goldhirsch Aron; Thürlimann Beat; Paridaens Robert; Smith Ian; Mauriac Louis; Forbes John F; Price Karen N; Regan Meredith M; Gelber Richard D; Coates Alan S
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
The New England journal of medicine 2009;361(8):766-76.
2009: Goldhirsch A; Ingle J N; Gelber R D; Coates A S; Thürlimann B; Senn H-J;
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1319-29.
2009: Colleoni M; Sun Z; Martinelli G; Basser R L; Coates A S; Gelber R D; Green M D; Peccatori F; Cinieri S; Aebi S; Viale G; Price K N; Goldhirsch A;
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1344-51.
2009: Pagani Olivia; Gelber Shari; Simoncini Edda; Castiglione-Gertsch Monica; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Collins John; Lindtner Jurij; Thürlimann Beat; Fey Martin F; Murray Elizabeth; Forbes John F; Coates Alan S; Goldhirsch Aron;
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Breast cancer research and treatment 2009;116(3):491-500.
2009: Colleoni Marco; Bagnardi Vincenzo; Rotmensz Nicole; Gelber Richard D; Viale Giuseppe; Pruneri Giancarlo; Veronesi Paolo; Torrisi Rosalba; Cardillo Anna; Montagna Emilia; Campagnoli Elisabetta; Luini Alberto; Intra Mattia; Galimberti Viviana; Scarano Eloise; Peruzzotti Giulia; Goldhirsch Aron
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
Breast cancer research and treatment 2009;116(2):359-69.
2009: Viale Giuseppe; Rotmensz Nicole; Maisonneuve Patrick; Bottiglieri Luca; Montagna Emilia; Luini Alberto; Veronesi Paolo; Intra Mattia; Torrisi Rosalba; Cardillo Anna; Campagnoli Elisabetta; Goldhirsch Aron; Colleoni Marco
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.
Breast cancer research and treatment 2009;116(2):317-28.
2009: Azim Hatem A; Peccatori Fedro A; Liptrott Sarah J; Catania Chiara; Goldhirsch Aron;
Breast cancer and pregnancy: how safe is trastuzumab?
Nature reviews. Clinical oncology 2009;6(6):367-70.
2009: Peccatori Fedro A; Azim Hatem A; Scarfone Giovanna; Gadducci Angiolo; Bonazzi Cristina; Gentilini Oreste; Galimberti Viviana; Intra Mattia; Locatelli Marzia; Acaia Barbara; Rossi Piero; Cinieri Saverio; Calabrese Liliana; Goldhirsch Aron
Weekly epirubicin in the treatment of gestational breast cancer (GBC).
Breast cancer research and treatment 2009;115(3):591-4.
2009: Veronesi Umberto; Zurrida Stefano; Goldhirsch Aron; Rotmensz Nicole; Viale Giuseppe
Breast cancer classification: time for a change.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2427-8.
2009: Biffi R; Orsi F; Pozzi S; Pace U; Bonomo G; Monfardini L; Della Vigna P; Rotmensz N; Radice D; Zampino M G; Fazio N; de Braud F; Andreoni B; Goldhirsch A
Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(5):935-40.
2009: Sun Zhuoxin; Goldhirsch Aron; Price Karen N; Colleoni Marco; Ravaioli Alberto; Simoncini Edda; Campbell Ian; Gelber Richard D; Towler Mark
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.
Breast (Edinburgh, Scotland) 2009;18(2):84-8.
2009: Balduzzi Alessandra; Montagna Emilia; Bagnardi Vincenzo; Torrisi Rosalba; Bertolini Francesco; Mancuso Patrizia; Scarano Eloise; Viale Giuseppe; Veronesi Paolo; Cardillo Anna; Orlando Laura; Goldhirsch Aron; Colleoni Marco
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
Anti-cancer drugs 2009;20(3):197-203.
2009: Gianni Lorenzo; Gelber Shari; Ravaioli Alberto; Price Karen N; Panzini Ilaria; Fantini Manuela; Castiglione-Gertsch Monica; Pagani Olivia; Simoncini Edda; Gelber Richard D; Coates Alan S; Goldhirsch Aron
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 2009;45(4):561-71.
2009: Gentilini Oreste; Botteri Edoardo; Rotmensz Nicole; Da Lima Luciana; Caliskan Mujgan; Garcia-Etienne Carlos A; Sosnovskikh Irina; Intra Mattia; Mazzarol Giovanni; Musmeci Simona; Veronesi Paolo; Galimberti Viviana; Luini Alberto; Viale Giuseppe; Goldhirsch Aron; Veronesi Umberto
Conservative surgery in patients with multifocal/multicentric breast cancer.
Breast cancer research and treatment 2009;113(3):577-83.
2009: Crivellari Diana; Colleoni Marco; Dellapasqua Silvia; Goldhirsch Aron
Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?
Tumori 2009;95(1):130; author reply 131.
2009: Rocca A; Minucci S; Tosti G; Croci D; Contegno F; Ballarini M; Nolè F; Munzone E; Salmaggi A; Goldhirsch A; Pelicci P G; Testori A
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.
British journal of cancer 2009;100(1):28-36.
2008: Viale Giuseppe; Giobbie-Hurder Anita; Regan Meredith M; Coates Alan S; Mastropasqua Mauro G; Dell'Orto Patrizia; Maiorano Eugenio; MacGrogan Gaëtan; Braye Stephen G; Ohlschlegel Christian; Neven Patrick; Orosz Zsolt; Olszewski Wojciech P; Knox Fiona; Thürlimann Beat; Price Karen N; Castiglione-Gertsch Monica; Gelber Richard D; Gusterson Barry A; Goldhirsch Aron;
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5569-75.
2008: Torrisi Rosalba; Dellapasqua Silvia; Ghisini Raffaella; Viale Giuseppe; Veronesi Paolo; Luini Alberto; Intra Mattia; Peruzzotti Giulia; Rocca Andrea; Balduzzi Alessandra; Cardillo Anna; Goldhirsch Aron; Colleoni Marco
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.
Breast (Edinburgh, Scotland) 2008;17(6):654-60.
2008: Torrisi R; Bagnardi V; Cardillo A; Bertolini F; Scarano E; Orlando L; Mancuso P; Luini A; Calleri A; Viale G; Goldhirsch A; Colleoni M
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.
British journal of cancer 2008;99(10):1564-71.
2008: Dellapasqua Silvia; Bertolini Francesco; Bagnardi Vincenzo; Campagnoli Elisabetta; Scarano Eloise; Torrisi Rosalba; Shaked Yuval; Mancuso Patrizia; Goldhirsch Aron; Rocca Andrea; Pietri Elisabetta; Colleoni Marco
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4899-905.
2008: Orlando Laura; Del Curto Barbara; Gandini Sara; Ghisini Raffaella; Pietri Elisabetta; Torrisi Rosalba; Balduzzi Alessandra; Cardillo Anna; Dellapasqua Silvia; Veronesi Paolo; Viale Giuseppe; Goldhirsch Aron; Colleoni Marco
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
Breast (Edinburgh, Scotland) 2008;17(5):506-11.
2008: D'Alessandro Claudia; Dellapasqua Silvia; Orlando Laura; Santoro Luigi; Maisonneuve Patrick; Torrisi Rosalba; Balduzzi Alessandra; Scarano Eloise; Ghisini Raffaella; Peruzzotti Giulia; Goldhirsch Aron; Colleoni Marco
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
The breast journal 2008;14(5):435-41.
2008: Torrisi Rosalba; Balduzzi Alessandra; Ghisini Raffaella; Rocca Andrea; Bottiglieri Luca; Giovanardi Filippo; Veronesi Paolo; Luini Alberto; Orlando Laura; Viale Giuseppe; Goldhirsch Aron; Colleoni Marco
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
Cancer chemotherapy and pharmacology 2008;62(4):667-72.
2008: Montagna E; Bagnardi V; Rotmensz N; Rodriguez J; Veronesi P; Luini A; Intra M; Scarano E; Cardillo A; Torrisi R; Viale G; Goldhirsch A; Colleoni M
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.
British journal of cancer 2008;98(11):1745-52.
2008: Pestalozzi Bernhard C; Zahrieh David; Mallon Elizabeth; Gusterson Barry A; Price Karen N; Gelber Richard D; Holmberg Stig B; Lindtner Jurij; Snyder Raymond; Thürlimann Beat; Murray Elizabeth; Viale Giuseppe; Castiglione-Gertsch Monica; Coates Alan S; Goldhirsch Aron;
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3006-14.
2008: Nolé F; Munzone E; Zorzino L; Minchella I; Salvatici M; Botteri E; Medici M; Verri E; Adamoli L; Rotmensz N; Goldhirsch A; Sandri M T
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):891-7.
2008: Rocca Andrea; Viale Giuseppe; Gelber Richard D; Bottiglieri Luca; Gelber Shari; Pruneri Giancarlo; Ghisini Raffaella; Balduzzi Alessandra; Pietri Elisabetta; D'Alessandro Claudia; Goldhirsch Aron; Colleoni Marco
Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
Cancer chemotherapy and pharmacology 2008;61(6):965-71.
2008: Crivellari Diana; Sun Zhuoxin; Coates Alan S; Price Karen N; Thürlimann Beat; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert J; Castiglione-Gertsch Monica; Gelber Richard D; Colleoni Marco; Láng István; Del Mastro Lucia; Gladieff Laurence; Rabaglio Manuela; Smith Ian E; Chirgwin Jacquie H; Goldhirsch Aron
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1972-9.
2008: Viale Giuseppe; Regan Meredith M; Maiorano Eugenio; Mastropasqua Mauro G; Golouh Rastko; Perin Tiziana; Brown Robert W; Kovács Anikó; Pillay Komala; Ohlschlegel Christian; Braye Stephen; Grigolato Piergiovanni; Rusca Tiziana; Gelber Richard D; Castiglione-Gertsch Monica; Price Karen N; Goldhirsch Aron; Gusterson Barry A; Coates Alan S
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1404-10.
2008: Curigliano Giuseppe; Spitaleri Gianluca; Fingert Howard J; de Braud Filippo; Sessa Cristiana; Loh Elwyn; Cipolla Carlo; De Pas Tommaso; Goldhirsch Aron; Shah Rashmi
Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development.
European journal of cancer (Oxford, England : 1990) 2008;44(4):494-500.
2008: Colleoni M; Viale G; Zahrieh D; Bottiglieri L; Gelber R D; Veronesi P; Balduzzi A; Torrisi R; Luini A; Intra M; Dellapasqua S; Cardillo A; Ghisini R; Peruzzotti G; Goldhirsch A
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):465-72.
2008: Viale Giuseppe; Regan Meredith M; Mastropasqua Mauro G; Maffini Fausto; Maiorano Eugenio; Colleoni Marco; Price Karen N; Golouh Rastko; Perin Tiziana; Brown R W; Kovács Anikó; Pillay Komala; Ohlschlegel Christian; Gusterson Barry A; Castiglione-Gertsch Monica; Gelber Richard D; Goldhirsch Aron; Coates Alan S;
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
Journal of the National Cancer Institute 2008;100(3):207-12.
2008: Francis Prudence; Crown John; Di Leo Angelo; Buyse Marc; Balil Ana; Andersson Michael; Nordenskjöld Bo; Lang Istvan; Jakesz Raimund; Vorobiof Daniel; Gutiérrez Jorge; van Hazel Guy; Dolci Stella; Jamin Sophie; Bendahmane Belguendouz; Gelber Richard D; Goldhirsch Aron; Castiglione-Gertsch Monica; Piccart-Gebhart Martine;
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Journal of the National Cancer Institute 2008;100(2):121-33.
2008: Rasmussen Birgitte B; Regan Meredith M; Lykkesfeldt Anne E; Dell'Orto Patrizia; Del Curto Barbara; Henriksen Katrine L; Mastropasqua Mauro G; Price Karen N; Méry Eliane; Lacroix-Triki Magali; Braye Stephen; Altermatt Hans J; Gelber Richard D; Castiglione-Gertsch Monica; Goldhirsch Aron; Gusterson Barry A; Thürlimann Beat; Coates Alan S; Viale Giuseppe;
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.
The lancet oncology 2008;9(1):23-8.
2008: Bernhard J; Zahrieh D; Zhang J J; Martinelli G; Basser R; Hürny C; Forbes J F; Aebi S; Yeo W; Thürlimann B; Green M D; Colleoni M; Gelber R D; Castiglione-Gertsch M; Price K N; Goldhirsch A; Coates A S;
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.
British journal of cancer 2008;98(1):25-33.
2008: Gianni Lorenzo; Cole Bernard F; Panzini Ilaria; Snyder Raymond; Holmberg Stig B; Byrne Michael; Crivellari Diana; Colleoni Marco; Aebi Stefan; Simoncini Edda; Pagani Olivia; Castiglione-Gertsch Monica; Price Karen N; Goldhirsch Aron; Coates Alan S; Ravaioli Alberto
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(1):67-74.
2008: Catania Chiara; De Pas Tommaso; Goldhirsch Aron; Radice Davide; Adamoli Laura; Medici Marta; Verri Elena; Marenghi Cristina; de Braud Filippo; Nolè Franco
Participation in clinical trials as viewed by the patient: understanding cultural and emotional aspects which influence choice.
Oncology 2008;74(3-4):177-87.
2008: Sanna G; Preda L; Bruschini R; Cossu Rocca M; Verri E; Bellomi M; Goldhirsch A; Nole F
The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates.
Acta oncologica (Stockholm, Sweden) 2008;47(3):476-8.
2007: Mouridsen Henning; Keshaviah Aparna; Coates Alan S; Rabaglio Manuela; Castiglione-Gertsch Monica; Sun Zhuoxin; Thürlimann Beat; Mauriac Louis; Forbes John F; Paridaens Robert; Gelber Richard D; Colleoni Marco; Smith Ian; Price Karen N; Goldhirsch Aron
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5715-22.
2007: Catania C; Medici M; Magni E; Munzone E; Cardinale D; Adamoli L; Sanna G; Minchella I; Radice D; Goldhirsch A; Nolè F
Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1969-75.
2007: Curigliano Giuseppe; Rescigno Maria; Goldhirsch Aron
Immunology and breast cancer: therapeutic cancer vaccines.
Breast (Edinburgh, Scotland) 2007;16 Suppl 2():S20-6.
2007: Cathomas Richard; Goldhirsch Aron; von Moos Roger
Drug-induced immune thrombocytopenia.
The New England journal of medicine 2007;357(18):1870-1; author reply 1871.
2007: Torrisi Rosalba; Rotmensz Nicole; Bagnardi Vincenzo; Viale Giuseppe; Curto Barbara Del; Dell'orto Patrizia; Veronesi Paolo; Luini Alberto; D'Alessandro Claudia; Cardillo Anna; Goldhirsch Aron; Colleoni Marco
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17.
European journal of cancer (Oxford, England : 1990) 2007;43(16):2339-44.
2007: Catania Chiara; Ascione Gilda; Adamoli Laura; De Pas Tommaso; Medici Marta; Franceschelli Lucia; Verri Elena; Magni Elena; Sanna Giuseppina; Torrisi Rosalba; Goldhirsch Aron; Nolè Franco
Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre.
Breast cancer research and treatment 2007;106(1):97-103.
2007: Colleoni M; Rotmensz N; Maisonneuve P; Sonzogni A; Pruneri G; Casadio C; Luini A; Veronesi P; Intra M; Galimberti V; Torrisi R; Andrighetto S; Ghisini R; Goldhirsch A; Viale G
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1632-40.
2007: Curigliano Giuseppe; Balduzzi Alessandra; Cardillo Anna; Ghisini Raffaella; Peruzzotti Giulia; Orlando Laura; Torrisi Rosalba; Dellapasqua Silvia; Lunghi Loredana; Goldhirsch Aron; Colleoni Marco
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(10):1213-7.
2007: Curigliano Giuseppe; Spitaleri Gianluca; Dettori Manuela; Locatelli Marzia; Scarano Eloise; Goldhirsch Aron
Vaccine immunotherapy in breast cancer treatment: promising, but still early.
Expert review of anticancer therapy 2007;7(9):1225-41.
2007: Fazio Nicola; Biffi Roberto; Curigliano Giuseppe; Lorizzo Katia; Zampino Maria Giulia; de Braud Filippo; Chiappa Antonio; Roth Arnaud; Goldhirsch Aron
Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Journal of the National Cancer Institute 2007;99(17):1345-6; author reply 1346-7.
2007: Torrisi R; Bagnardi V; Pruneri G; Ghisini R; Bottiglieri L; Magni E; Veronesi P; D'Alessandro C; Luini A; Dellapasqua S; Viale G; Goldhirsch A; Colleoni M
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer.
British journal of cancer 2007;97(6):802-8.
2007: Viale Giuseppe; Regan Meredith M; Maiorano Eugenio; Mastropasqua Mauro G; Dell'Orto Patrizia; Rasmussen Birgitte Bruun; Raffoul Johnny; Neven Patrick; Orosz Zsolt; Braye Stephen; Ohlschlegel Christian; Thürlimann Beat; Gelber Richard D; Castiglione-Gertsch Monica; Price Karen N; Goldhirsch Aron; Gusterson Barry A; Coates Alan S
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3846-52.
2007: Curigliano Giuseppe; Goldhirsch Aron
To switch or not to switch: implications of sequencing adjuvant endocrine therapy in patients with breast cancer.
Nature clinical practice. Oncology 2007;4(9):510-1.
2007: Dellapasqua Silvia; Colleoni Marco; Castiglione Monica; Goldhirsch Aron
New criteria for selecting elderly patients for breast cancer adjuvant treatment studies.
The oncologist 2007;12(8):952-9.
2007: Sanna G; Franceschelli L; Rotmensz N; Botteri E; Adamoli L; Marenghi C; Munzone E; Cossu Rocca M; Verri E; Minchella I; Medici M; Catania C; Magni E; Goldhirsch A; Nolè F
Brain metastases in patients with advanced breast cancer.
Anticancer research 2007;27(4C):2865-9.
2007: Goldhirsch A; Wood W C; Gelber R D; Coates A S; Thürlimann B; Senn H-J;
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1133-44.
2007: Partridge Ann; Gelber Shari; Gelber Richard D; Castiglione-Gertsch Monica; Goldhirsch Aron; Winer Eric
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1646-53.
2007: Colleoni Marco; Gelber Shari; Simoncini Edda; Pagani Olivia; Gelber Richard D; Price Karen N; Castiglione-Gertsch Monica; Coates Alan S; Goldhirsch Aron
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1177-84.
2007: Veronesi Giulia; Scanagatta Paolo; Goldhirsch Aron; Rietjens Mario; Colleoni Marco; Pelosi Giuseppe; Spaggiari Lorenzo
Results of chest wall resection for recurrent or locally advanced breast malignancies.
Breast (Edinburgh, Scotland) 2007;16(3):297-302.
2007: Crivellari Diana; Aapro Matti; Leonard Robert; von Minckwitz Gunter; Brain Etienne; Goldhirsch Aron; Veronesi Andrea; Muss Hyman
Breast cancer in the elderly.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(14):1882-90.
2007: Karlsson Per; Cole Bernard F; Price Karen N; Coates Alan S; Castiglione-Gertsch Monica; Gusterson Barry A; Murray Elizabeth; Lindtner Jurij; Collins John P; Holmberg Stig B; Fey Martin F; Thürlimann Beat; Crivellari Diana; Forbes John F; Gelber Richard D; Goldhirsch Aron; Wallgren Arne
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2019-26.
2007: Mauriac L; Keshaviah A; Debled M; Mouridsen H; Forbes J F; Thürlimann B; Paridaens R; Monnier A; Láng I; Wardley A; Nogaret J-M; Gelber R D; Castiglione-Gertsch M; Price K N; Coates A S; Smith I; Viale G; Rabaglio M; Zabaznyi N; Goldhirsch A;
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):859-67.
2007: Saletti Piercarlo; Berthold Dominique; Ghielmini Michele; Zucca Emanuele; Fazio Nicola; Goldhirsch Aron; Cavalli Franco
Adjuvant chemotherapy (ECF regimen) for patients with gastric adenocarcinoma.
Hepato-gastroenterology 2007;54(75):969-72.
2007: Keshaviah A; Dellapasqua S; Rotmensz N; Lindtner J; Crivellari D; Collins J; Colleoni M; Thürlimann B; Mendiola C; Aebi S; Price K N; Pagani O; Simoncini E; Castiglione Gertsch M; Gelber R D; Coates A S; Goldhirsch A
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):701-8.
2007: Piccart Martine; Goldhirsch Aron; Wood William; Pritchard Kathleen; Baselga José; Reaby Linda; Kössler Ingrid; Kyriakides Stella; Norton Larry; Coates Alan
Keeping faith with trial volunteers.
Nature 2007;446(7132):137-8.
2007: Goldhirsch Aron; Price Karen N
Comparing aromatase inhibitors in the absence of clinical trial results can be misleading.
Journal of surgical oncology 2007;95(4):355-6; author reply 357.
2007: Gentilini O; Botteri E; Rotmensz N; Santillo B; Peradze N; Saihum R C; Intra M; Luini A; Galimberti V; Goldhirsch A; Veronesi U
When can a second conservative approach be considered for ipsilateral breast tumour recurrence?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):468-72.
2007: Coates Alan S; Keshaviah Aparna; Thürlimann Beat; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert; Castiglione-Gertsch Monica; Gelber Richard D; Colleoni Marco; Láng István; Del Mastro Lucia; Smith Ian; Chirgwin Jacquie; Nogaret Jean-Marie; Pienkowski Tadeusz; Wardley Andrew; Jakobsen Erik H; Price Karen N; Goldhirsch Aron
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):486-92.
2007: Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):288-92.
2007: Cardillo A; De Cicco C; Paganelli G; Ghisini R; Peruzzotti G; Balduzzi A; Goldhirsch A; Rotmensz N; Veronesi P; Luini A; Intra M; Colleoni M
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):394-5.
2007: Torrisi Rosalba; Colleoni Marco; Veronesi Paolo; Rocca Andrea; Peruzzotti Giulia; Severi Gianluca; Medici Marta; Renne Giuseppe; Intra Mattia; Luini Alberto; Nolè Franco; Viale Giuseppe; Goldhirsch Aron
Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2-T4 breast cancer.
Breast (Edinburgh, Scotland) 2007;16(1):73-80.
2007: Smith Ian; Procter Marion; Gelber Richard D; Guillaume Sébastien; Feyereislova Andrea; Dowsett Mitch; Goldhirsch Aron; Untch Michael; Mariani Gabriella; Baselga Jose; Kaufmann Manfred; Cameron David; Bell Richard; Bergh Jonas; Coleman Robert; Wardley Andrew; Harbeck Nadia; Lopez Roberto I; Mallmann Peter; Gelmon Karen; Wilcken Nicholas; Wist Erik; Sánchez Rovira Pedro; Piccart-Gebhart Martine J;
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
Lancet 2007;369(9555):29-36.
2007: Bernhard Jürg; Zahrieh David; Castiglione-Gertsch Monica; Hürny Christoph; Gelber Richard D; Forbes John F; Murray Elizabeth; Collins John; Aebi Stefan; Thürlimann Beat; Price Karen N; Goldhirsch Aron; Coates Alan S;
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):263-70.
2007: Conti-Beltraminelli M; Pagani O; Ballerini G; Richetti A; Graffeo R; Ruggeri M; Forni V; Pianca S; Schönholzer C; Mainetti C; Cavalli F; Goldhirsch A
Henoch-Schönlein purpura (HSP) during treatment with anastrozole.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):205-7.
2007: Perey L; Paridaens R; Hawle H; Zaman K; Nolé F; Wildiers H; Fiche M; Dietrich D; Clément P; Köberle D; Goldhirsch A; Thürlimann B
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):64-9.
2007: Dowsett Mitch; Goldhirsch Aron; Hayes Daniel F; Senn Hans-Joerg; Wood William; Viale Giuseppe
International Web-based consultation on priorities for translational breast cancer research.
Breast cancer research : BCR 2007;9(6):R81.
2007: Di Meglio Giovanni; Fazio Nicola; Nolè Franco; Della Vigna Paolo; Lorizzo Katia; Goldhirsch Aron; Farris Antonio
Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
Acta oncologica (Stockholm, Sweden) 2007;46(8):1205-6.
2006: Goldhirsch A; Coates A S; Gelber R D; Glick J H; Thürlimann B; Senn H-J;
First--select the target: better choice of adjuvant treatments for breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1772-6.
2006: Dellapasqua Silvia; Colleoni Marco; Goldhirsch Aron
Focusing on physical function limitations in elderly women surviving cancer: any opportunity for improvement?
Nature clinical practice. Oncology 2006;3(11):598-9.
2006: Regan Meredith M; Viale Giuseppe; Mastropasqua Mauro G; Maiorano Eugenio; Golouh Rastko; Carbone Antonino; Brown Bob; Suurküla Mart; Langman Gerald; Mazzucchelli Luca; Braye Stephen; Grigolato Piergiovanni; Gelber Richard D; Castiglione-Gertsch Monica; Price Karen N; Coates Alan S; Goldhirsch Aron; Gusterson Barry;
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Journal of the National Cancer Institute 2006;98(21):1571-81.
2006: Rocca Andrea; Peruzzotti Giulia; Ghisini Raffaella; Viale Giuseppe; Veronesi Paolo; Luini Alberto; Intra Mattia; Pietri Elisabetta; Curigliano Giuseppe; Giovanardi Filippo; Maisonneuve Patrick; Goldhirsch Aron; Colleoni Marco
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer.
Anti-cancer drugs 2006;17(10):1201-9.
2006: Catania Chiara; De Pas Tommaso Martino; Pelosi Giuseppe; Manzotti Michela; Adamoli Laura; Nolè Franco; Goldhirsch Aron
Erlotinib-induced breast cancer regression.
The Annals of pharmacotherapy 2006;40(11):2043-7.
2006: Gentilini Oreste; Intra Mattia; Gandini Sara; Peruzzotti Giulia; Winnikow Erik; Luini Alberto; Veronesi Paolo; Galimberti Viviana; Goldhirsch Aron; Veronesi Umberto
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome.
Journal of surgical oncology 2006;94(5):375-9.
2006: Sanna G; Preda L; Bruschini R; Cossu Rocca M; Ferretti S; Adamoli L; Verri E; Franceschelli L; Goldhirsch A; Nolè F
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1512-6.
2006: Colleoni M; Rotmensz N; Peruzzotti G; Maisonneuve P; Orlando L; Ghisini R; Viale G; Pruneri G; Veronesi P; Luini A; Intra M; Cardillo A; Torrisi R; Rocca A; Goldhirsch A
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1497-503.
2006: Pagani Olivia; Goldhirsch Aron
Breast cancer in young women: climbing for progress in care and knowledge.
Women's health (London, England) 2006;2(5):717-32.
2006: Torrisi R; Orlando L; Ghisini R; Veronesi P; Intra M; Rocca A; Balduzzi A; Cardillo A; Goldhirsch A; Colleoni M
A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancer.
Anticancer research 2006;26(5B):3861-4.
2006: Orlando Laura; Cardillo Anna; Rocca Andrea; Balduzzi Alessandra; Ghisini Raffaella; Peruzzotti Giulia; Goldhirsch Aron; D'Alessandro Claudia; Cinieri Saverio; Preda Lorenzo; Colleoni Marco
Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
Anti-cancer drugs 2006;17(8):961-7.
2006: Mancuso Patrizia; Colleoni Marco; Calleri Angelica; Orlando Laura; Maisonneuve Patrick; Pruneri Giancarlo; Agliano Alice; Goldhirsch Aron; Shaked Yuval; Kerbel Robert S; Bertolini Francesco
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy.
Blood 2006;108(2):452-9.
2006: Curigliano G; Formica V; De Pas T; Spitaleri G; Pietri E; Fazio N; de Braud F; Goldhirsch A
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(7):1174-5.
2006: Pestalozzi B C; Zahrieh D; Price K N; Holmberg S B; Lindtner J; Collins J; Crivellari D; Fey M F; Murray E; Pagani O; Simoncini E; Castiglione-Gertsch M; Gelber R D; Coates A S; Goldhirsch A;
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):935-44.
2006: Zampino M G; Verri E; Locatelli M; Curigliano G; Ascione G; Sbanotto A; Rocca A; Verweij F; Matei V; Scardino E; Decobelli O; Goldhirsch A; Nolè F
Vinorelbine-based chemotherapy in hormone-refractory prostate cancer.
Anticancer research 2006;26(3B):2375-80.
2006: Curigliano G; Spitaleri G; Pietri E; Rescigno M; de Braud F; Cardillo A; Munzone E; Rocca A; Bonizzi G; Brichard V; Orlando L; Goldhirsch A
Breast cancer vaccines: a clinical reality or fairy tale?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(5):750-62.
2006: Cinieri Saverio; Colleoni Marco; Zurrida Stefano; Goldhirsch Aron; Veronesi Umberto
Innovation in care and research: meeting highlights from the seventh Milan Breast Cancer Conference (Milan, 15-17 June, 2005).
Breast (Edinburgh, Scotland) 2006;15(2):232-45.
2006: Kaufmann Manfred; Hortobagyi Gabriel N; Goldhirsch Aron; Scholl Suzy; Makris Andreas; Valagussa Pinuccia; Blohmer Jens-Uwe; Eiermann Wolfgang; Jackesz Raimund; Jonat Walter; Lebeau Annette; Loibl Sibylle; Miller William; Seeber Sigfried; Semiglazov Vladimir; Smith Roy; Souchon Rainer; Stearns Vered; Untch Michael; von Minckwitz Gunter
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
2006: Colleoni Marco; Gelber Shari; Goldhirsch Aron; Aebi Stefan; Castiglione-Gertsch Monica; Price Karen N; Coates Alan S; Gelber Richard D
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1332-41.
2006: Nolè Franco; Catania Chiara; Munzone Elisabetta; Rocca Andrea; Verri Elena; Sanna Giuseppina; Ascione Gilda; Adamoli Laura; Zampino Maria G; Minchella Ida; Goldhirsch Aron
Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.
Clinical breast cancer 2006;6(6):518-24.
2006: Veronesi Umberto; Viale Giuseppe; Rotmensz Nicole; Goldhirsch Aron
Rethinking TNM: breast cancer TNM classification for treatment decision-making and research.
Breast (Edinburgh, Scotland) 2006;15(1):3-8.
2006: Gianni Lorenzo; Panzini Ilaria; Li Sigui; Gelber Richard D; Collins John; Holmberg Stig B; Crivellari Diana; Castiglione-Gertsch Monica; Goldhirsch Aron; Coates Alan S; Ravaioli Alberto;
Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Cancer 2006;106(3):505-13.
2006: Colleoni M; Orlando L; Sanna G; Rocca A; Maisonneuve P; Peruzzotti G; Ghisini R; Sandri M T; Zorzino L; Nolè F; Viale G; Goldhirsch A
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):232-8.
2006: Nolè F; Catania C; Sanna G; Imadalou K; Munzone E; Adamoli L; Longerey B; Blanchot G; Goldhirsch A
Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):322-9.
2006: Curigliano Giuseppe; Mandalà Mario; Sbanotto Alberto; Colleoni Marco; Ferretti Gianluigi; Bucciarelli Paolo; Peruzzotti Giulia; de Braud Filippo; De Pas Tommaso; Spitaleri Gianluca; Pietri E; Orsi Franco; Banfi Maria G; Goldhirsch Aron
Factor v leiden mutation in patients with breast cancer with a central venous catheter: risk of deep vein thrombosis.
Supportive cancer therapy 2006;3(2):98-102.
2006: Basser Russell L; O'Neill Anne; Martinelli Giovanni; Green Michael D; Peccatori Fedro; Cinieri Saverio; Coates Alan S; Gelber Richard D; Aebi Stefan; Castiglione-Gertsch Monica; Viale Guiseppe; Price Karen N; Goldhirsch Aron
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):370-8.
2006: Rudenstam Carl-Magnus; Zahrieh David; Forbes John F; Crivellari Diana; Holmberg Stig B; Rey Piercarlo; Dent David; Campbell Ian; Bernhard Jürg; Price Karen N; Castiglione-Gertsch Monica; Goldhirsch Aron; Gelber Richard D; Coates Alan S
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):337-44.
2006: Orlando Laura; Cardillo Anna; Ghisini Raffaella; Rocca Andrea; Balduzzi Alessandra; Torrisi Rosalba; Peruzzotti Giulia; Goldhirsch Aron; Pietri Elisabetta; Colleoni Marco
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
BMC cancer 2006;6():225.
2006: Curigliano Giuseppe; Magni Elena; Renne Giuseppe; De Cobelli Ottavio; Rescigno Maria; Torrisi Rosalba; Spitaleri Gianluca; Pietri Elisabetta; De Braud Filippo; Goldhirsch Aron
"Burned out" phenomenon of the testis in retroperitoneal seminoma.
Acta oncologica (Stockholm, Sweden) 2006;45(3):335-6.
2006: Munzone Elisabetta; Curigliano Giuseppe; Rocca Andrea; Bonizzi Giuseppina; Renne Giuseppe; Goldhirsch Aron; Nolè Franco
Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.
Breast cancer research : BCR 2006;8(1):R4.
2005: Thürlimann Beat; Keshaviah Aparna; Coates Alan S; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert; Castiglione-Gertsch Monica; Gelber Richard D; Rabaglio Manuela; Smith Ian; Wardley Andrew; Price Karen N; Goldhirsch Aron
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
The New England journal of medicine 2005;353(26):2747-57.
2005: Munzone E; Nolè F; Sanna G; Goldhirsch A
Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab.
Breast (Edinburgh, Scotland) 2005;14(5):380-3.
2005: Curigliano Giuseppe; Colleoni Marco; Mandalà Mario; De Pas Tommaso; Spitaleri Gianluca; de Braud Filippo; Goldhirsch Aron
Prophylaxis for venous thromboembolism in cancer patients with a central vein catheter: new tones for an old song.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7243-4; author reply 7244.
2005: Gruber Günther; Bonetti Marco; Nasi M Laura; Price Karen N; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Holmberg Stig B; Lindtner Jurij; Golouh Rastko; Collins John; Crivellari Diana; Carbone Antonino; Thürlimann Beat; Simoncini Edda; Fey Martin F; Gelber Richard D; Coates Alan S; Goldhirsch Aron;
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7089-97.
2005: Goldhirsch A; Glick J H; Gelber R D; Coates A S; Thürlimann B; Senn H-J;
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1569-83.
2005: Pagani O; Sessa C; Nolè F; Munzone E; Crivellari D; Lombardi D; Thürlimann B; Hess D; Graffeo R; Ruggeri M; Longhi S; Goldhirsch A
Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1609-17.
2005: Goldhirsch Aron; Gelber Richard D; Coates Alan S
What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer?
Nature clinical practice. Oncology 2005;2(9):440-1.
2005: Curigliano G; Petit J Y; Bertolini F; Colleoni M; Peruzzotti G; de Braud F; Gandini S; Giraldo A; Martella S; Orlando L; Munzone E; Pietri E; Luini A; Goldhirsch A
Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
Breast cancer research and treatment 2005;93(1):35-40.
2005: Colleoni Marco; Li Sigui; Gelber Richard D; Price Karen N; Coates Alan S; Castiglione-Gertsch Monica; Goldhirsch Aron;
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.
Lancet 2005;366(9491):1108-10.
2005: Catania Chiara; Didier Florence; Leon Maria Elena; Sbanotto Alberto; Mariani Luigi; Nolè Franco; Leida Elena; Rocca Andrea; De Pas Tommaso; Goldhirsch Aron
Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer.
Breast cancer research and treatment 2005;92(3):265-72.
2005: Orlando L; Renne G; Rocca A; Curigliano G; Colleoni M; Severi G; Peruzzotti G; Cinieri S; Viale G; Sanna G; Goldhirsch A
Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1094-9.
2005: Sanna G; Zampino M G; Pelosi G; Nolè F; Goldhirsch A
Jaw avascular bone necrosis associated with long-term use of biphosphonates.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1207-8.
2005: Veronesi Umberto; Boyle Peter; Goldhirsch Aron; Orecchia Roberto; Viale Giuseppe
Breast cancer.
Lancet 2005;365(9472):1727-41.
2005: Goldhirsch Aron; Gelber Richard D; Viale Giuseppe; Colleoni Marco; Coates Alan S
Prediction of cancer outcome with microarrays.
Lancet 2005;365(9472):1685-6; author reply 1686.
2005: Colleoni M; Li S; Gelber R D; Coates A S; Castiglione-Gertsch M; Price K N; Lindtner J; Rudenstam C-M; Crivellari D; Collins J; Pagani O; Simoncini E; Thürlimann B; Murray E; Forbes J; Erzen D; Holmberg S; Veronesi A; Goldhirsch A
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):716-25.
2005: Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U
Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(3):232-6.
2005: De Pas T; Colleoni M; Orlando L; Masci G; Rocca A; Catania C; Curigliano G; Manzoni S; Goldhirsch A; de Braud F
Reply to the article "Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity" by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543-1550): ... and in humans?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):673.
2005: Dellapasqua Silvia; Colleoni Marco; Gelber Richard D; Goldhirsch Aron
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1736-50.
2005: Colleoni Marco; Zahrieh David; Gelber Richard D; Holmberg Stig B; Mattsson Jan E; Rudenstam Carl-Magnus; Lindtner Jurij; Erzen Darja; Snyder Raymond; Collins John; Fey Martin F; Thürlimann Beat; Crivellari Diana; Murray Elizabeth; Mendiola Caesar; Pagani Olivia; Castiglione-Gertsch Monica; Coates Alan S; Price Karen; Goldhirsch Aron
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1390-400.
2005: Colleoni Marco; Rotmensz Nicole; Peruzzotti Giulia; Maisonneuve Patrick; Mazzarol Giovanni; Pruneri Giancarlo; Luini Alberto; Intra Mattia; Veronesi Paolo; Galimberti Viviana; Torrisi Rosalba; Cardillo Anna; Goldhirsch Aron; Viale Giuseppe
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1379-89.
2005: Price Karen N; Goldhirsch Aron;
Clinical trial update: International Breast Cancer Study Group.
Breast cancer research : BCR 2005;7(6):252-4.
2005: Gennari Roberto; Cinieri Saverio; Colleoni Marco; Zurrida Stefano; Goldhirsch Aron; Veronesi Umberto
The 6th Milan Breast Cancer Conference, Milan, Italy, 16-18 June 2004.
Breast cancer research : BCR 2005;7(1):E1.
2004: Goldhirsch Aron; Gelber Richard D
Life with consequences of breast cancer: pregnancy during and after endocrine therapies.
Breast (Edinburgh, Scotland) 2004;13(6):443-5.
2004: Fazio N; De Pas T; de Braud F; Spaggiari L; Mazzarol G; Biffi R; Andreoni B; Zampino M; Curigliano G; Lorizzo K; Di Meglio G; Goldhirsch A
CDX-2 should be included in the work-up of patients with lung metastases from unknown primary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1850.
2004: Hess D; Thürlimann B; Pagani O; Aebi S; Rauch D; Ballabeni P; Rufener B; Castiglione-Gertsch M; Goldhirsch A;
Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1760-5.
2004: Pagani Olivia; Gelber Shari; Price Karen; Zahrieh David; Gelber Richard; Simoncini Edda; Castiglione-Gertsch Monica; Coates Alan S; Goldhirsch Aron
Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1749-59.
2004: Bernhard J; Zahrieh D; Coates A S; Gelber R D; Castiglione-Gertsch M; Murray E; Forbes J F; Perey L; Collins J; Snyder R; Rudenstam C-M; Crivellari D; Veronesi A; Thürlimann B; Fey M F; Price K N; Goldhirsch A; Hürny C
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.
British journal of cancer 2004;91(11):1893-901.
2004: Colleoni M; Rotmensz N; Peruzzotti G; Maisonneuve P; Viale G; Renne G; Casadio C; Veronesi P; Intra M; Torrisi R; Goldhirsch A
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(11):1633-9.
2004: Colleoni Marco; Viale Giuseppe; Zahrieh David; Pruneri Giancarlo; Gentilini Oreste; Veronesi Paolo; Gelber Richard D; Curigliano Giuseppe; Torrisi Rosalba; Luini Alberto; Intra Mattia; Galimberti Viviana; Renne Giuseppe; Nolè Franco; Peruzzotti Giulia; Goldhirsch Aron
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6622-8.
2004: Sabbioni Marzio E E; Bernhard Jürg; Siegrist Hans-Peter; Schmitz Shu-Fang Hsu; Gertsch Monica Castiglione; Thürlimann Beat; Bonnefoi Hervé; Perey Lucien; Herrmann Richard; Goldhirsch Aron; Hürny Christoph;
Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy?
Breast cancer research and treatment 2004;87(1):75-86.
2004: Intra Mattia; Rotmensz Nicole; Viale Giuseppe; Mariani Luigi; Bonanni Bernardo; Mastropasqua Mauro G; Galimberti Viviana; Gennari Roberto; Veronesi Paolo; Colleoni Marco; Tousimis Eleni; Galli Arianna; Goldhirsch Aron; Veronesi Umberto
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.
Cancer 2004;101(5):905-12.
2004: Gennari Roberto; Curigliano Giuseppe; Rotmensz Nicole; Robertson Chris; Colleoni Marco; Zurrida Stefano; Nolè Franco; de Braud Filippo; Orlando Laura; Leonardi Maria Cristina; Galimberti Viviana; Intra Mattia; Veronesi Paolo; Renne Giuseppe; Cinieri Saverio; Audisio Riccardo A; Luini Alberto; Orecchia Roberto; Viale Giuseppe; Goldhirsch Aron
Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.
Cancer 2004;101(6):1302-10.
2004: Peccatori Fedro; Martinelli Giovanni; Gentilini Oreste; Goldhirsch Aron
Chemotherapy during pregnancy: what is really safe?
The lancet oncology 2004;5(7):398.
2004: Saletti P; Ghielmini M; Martinoli S; Goldhirsch A
Sustained complete remission of metastatic oesophageal adenocarcinoma using long-term therapy with 5-fluorouracil.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1145-6.
2004: Curigliano Giuseppe; Rigo Rodrigo; Colleoni Marco; Braud Fillippo De; Nole Franco; Formica Vincenzo; Orlando Laura; Cinieri Saverio; Torrisi Rosalba; Cardillo Anna; Peruzzotti Giulia; Medici Marta; Ardito Raffaelle; Minchella Ida; Goldhirsch Aron
Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features.
Clinical breast cancer 2004;5(2):125-30.
2004: Rabascio Cristina; Muratori Elisabetta; Mancuso Patrizia; Calleri Angelica; Raia Valentina; Foutz Thomas; Cinieri Saverio; Veronesi Giulia; Pruneri Giancarlo; Lampertico Pietro; Iavarone Massimo; Martinelli Giovanni; Goldhirsch Aron; Bertolini Francesco
Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
Cancer research 2004;64(12):4373-7.
2004: Berclaz G; Li S; Price K N; Coates A S; Castiglione-Gertsch M; Rudenstam C-M; Holmberg S B; Lindtner J; Erien D; Collins J; Snyder R; Thürlimann B; Fey M F; Mendiola C; Werner I Dudley; Simoncini E; Crivellari D; Gelber R D; Goldhirsch A;
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):875-84.
2004: Thürlimann Beat; Hess Dagmar; Köberle Dieter; Senn Isabella; Ballabeni Pierluigi; Pagani Olivia; Perey Lucien; Aebi Stefan; Rochlitz Christoph; Goldhirsch Aron
Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.
Breast cancer research and treatment 2004;85(3):247-54.
2004: Roth A D; Maibach R; Fazio N; Sessa C; Stupp R; Morant R; Herrmann R; Borner M M; Goldhirsch A; de Braud F
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(5):759-64.
2004: Laszlo Daniele; Agazzi Alberto; Goldhirsch Aron; Cinieri Saverio; Bertolini Francesco; Rabascio Cristina; Pruneri Giancarlo; Calabrese Liliana; Cocquio Angela; Martinelli Giovanni
Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
European journal of haematology 2004;72(4):264-7.
2004: Mandalà M; Curigliano G; Bucciarelli P; Ferretti G; Mannucci P M; Colleoni M; Ventura A; Peruzzotti G; Severi G; Pelicci P G; Biffi R; Orsi F; Cinieri S; Goldhirsch A
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(4):590-3.
2004: Crivellari Diana; Goldhirsch Aron; Coates Alan
Hormonal treatment duration in elderly patients: an open question.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1164-5; author reply 1165.
2004: Biganzoli L; Goldhirsch A; Straehle C; Castiglione-Gertsch M; Therasse P; Aapro M; Minisini A; Piccart M J;
Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):207-10.
2003: Castiglione-Gertsch Monica; O'Neill Anne; Price Karen N; Goldhirsch Aron; Coates Alan S; Colleoni Marco; Nasi M Laura; Bonetti Marco; Gelber Richard D
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
Journal of the National Cancer Institute 2003;95(24):1833-46.
2003: Crivellari Diana; Price Karen; Gelber Richard D; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Lindtner Jurij; Fey Martin F; Senn Hans-Jörg; Coates Alan S; Collins John; Goldhirsch Aron;
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4517-23.
2003: Senn H-J; Thürlimann B; Goldhirsch A; Wood W C; Gelber R D; Coates A S
Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer.
Breast (Edinburgh, Scotland) 2003;12(6):569-82.
2003: Gelber R D; Bonetti M; Castiglione-Gertsch M; Coates A S; Goldhirsch A;
Tailoring adjuvant treatments for the individual breast cancer patient.
Breast (Edinburgh, Scotland) 2003;12(6):558-68.
2003: Colleoni M; Zahrieh D; Gelber R D; Viale G; Luini A; Veronesi P; Intra M; Galimberti V; Renne G; Goldhirsch A;
Preoperative systemic treatment: prediction of responsiveness.
Breast (Edinburgh, Scotland) 2003;12(6):538-42.
2003: Colleoni M; Curigliano G; Minchella I; Peruzzotti G; Nolè F; Mazzarol G; Renne G; Orlando L; Rocca A; Veronesi P; Intra M; Viale G; Sandri M T; Severi G; Goldhirsch A
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(10):1477-83.
2003: Bonomo Marco; Mingrone Walter; Brauchli Peter; Hering Franz; Goldhirsch Aron;
Exemestane seems to stimulate tumour growth in men with prostate carcinoma.
European journal of cancer (Oxford, England : 1990) 2003;39(14):2111-2.
2003: Goldhirsch Aron; Wood William C; Gelber Richard D; Coates Alan S; Thürlimann Beat; Senn Hans-Jörg
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3357-65.
2003: Waeber M; Castiglione-Gertsch M; Dietrich D; Thürlimann B; Goldhirsch A; Brunner K W; Borner M M;
Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1215-21.
2003: Goldhirsch A; Colleoni M; Domenighetti G; Gelber R D
Systemic treatments for women with breast cancer: outcome with relation to screening for the disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1212-4.
2003: Veronesi U; Goldhirsch A; Costa A; Zurrida S
New technologies for diagnosis and treatment of breast cancer: meeting highlights from the Fourth Milan Breast Cancer Conference (Milan, June 5-7, 2002).
Breast (Edinburgh, Scotland) 2003;12(3):223-35.
2003: Decensi Andrea; Robertson Chris; Viale Giuseppe; Pigatto Francesca; Johansson Harriet; Kisanga Elton R; Veronesi Paolo; Torrisi Rosalba; Cazzaniga Massimiliano; Mora Serena; Sandri Maria T; Pelosi Giuseppe; Luini Alberto; Goldhirsch Aron; Lien Ernst A; Veronesi Umberto
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
Journal of the National Cancer Institute 2003;95(11):779-90.
2003: Colleoni Marco; Goldhirsch Aron
Adjuvant chemotherapy in breast cancer: back to the future.
Onkologie 2003;26(2):111-2.
2003: Wallgren A; Bonetti M; Gelber R D; Goldhirsch A; Castiglione-Gertsch M; Holmberg S B; Lindtner J; Thürlimann B; Fey M; Werner I D; Forbes J F; Price K; Coates A S; Collins J;
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1205-13.
2003: Spataro Vito J; Litman Heather; Viale Giuseppe; Maffini Fausto; Masullo Michele; Golouh Rastko; Martinez-Tello Francisco J; Grigolato Piergioranni; Shilkin Keith B; Gusterson Barry A; Castiglione-Gertsch Monica; Price Karen; Lindtner Jurii; Cortés-Funes Hernan; Simoncini Edda; Byrne Michael J; Collins John; Gelber Richard D; Coates Alan S; Goldhirsch Aron;
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Cancer 2003;97(7):1591-600.
2003: Trihia Helen; Murray Susan; Price Karen; Gelber Richard D; Golouh Rastko; Goldhirsch Aron; Coates Alan S; Collins John; Castiglione-Gertsch Monica; Gusterson Barry A;
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?
Cancer 2003;97(5):1321-31.
2003: Colleoni Marco; Goldhirsch Aron
Adjuvant systemic therapies for patients with breast cancer: endocrine responsiveness and effects of chemotherapy.
Current problems in cancer 2003;27(1):13-6.
2002: Orlando Laura; Curigliano Giuseppe; Colleoni Marco; Fazio Nicola; Nole Franco; Martinelli Giovanni; Cinieri Saverio; Graffeo Rossella; Peruzzotti Giulia; Goldhirsch Aron
Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Anticancer research 2002;22(5):3057-9.
2002: Goldhirsch Aron
An interview with Dr. Aron Goldhirsch.
European journal of cancer (Oxford, England : 1990) 2002;38(14):1814.
2002: Coates Alan; Goldhirsch Aron; Gelber Richard;
Overhauling the breast cancer overview: are subsets subversive?
The lancet oncology 2002;3(9):525-6.
2002: Curigliano G; Colleoni M; Renne G; Mazzarol G; Gennari R; Peruzzotti G; de Braud E; Robertson C; Maiorano E; Veronesi P; Nolè F; Mandalà M; Ferretti G; Viale G; Goldhirsch A
Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):895-902.
2002: Colleoni M; Litman H J; Castiglione-Gertsch M; Sauerbrei W; Gelber R D; Bonetti M; Coates A S; Schumacher M; Bastert G; Rudenstam C-M; Schmoor C; Lindtner J; Collins J; Thürlimann B; Holmberg S B; Crivellari D; Beyerle C; Neumann R L A; Goldhirsch A;
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.
British journal of cancer 2002;86(11):1705-14.
2002: Borner Markus M; Dietrich Daniel; Stupp Roger; Morant Rudolf; Honegger Hanspeter; Wernli Martin; Herrmann Richard; Pestalozzi Bernhard C; Saletti Piercarlo; Hanselmann Silvia; Müller Samuel; Brauchli Peter; Castiglione-Gertsch Monica; Goldhirsch Aron; Roth Arnaud D
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1759-66.
2002: Curigliano Guiseppe; Mandala Mario; Minchella Ida; Goldhirsch Aron
Mediastinal lymphoadenopathy in a patient with breast cancer.
The lancet oncology 2002;3(3):174.
2002: Colleoni M; Rotmensz N; Robertson C; Orlando L; Viale G; Renne G; Luini A; Veronesi P; Intra M; Orecchia R; Catalano G; Galimberti V; Nolé F; Martinelli G; Goldhirsch A
Very young women (<35 years) with operable breast cancer: features of disease at presentation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):273-9.
2002: Colleoni M; Rocca A; Sandri M T; Zorzino L; Masci G; Nolè F; Peruzzotti G; Robertson C; Orlando L; Cinieri S; de Braud F; Viale G; Goldhirsch A
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(1):73-80.
2002: Goldhirsch A; Colleoni M; Gelber R D
Endocrine therapy of breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():61-8.
2001: Orlando L; Colleoni M; Curigliano G; Nolè F; Ferretti G; Masci G; Peruzzotti G; Minchella I; Intra M; Veronesi P; Viale G; Goldhirsch A
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
Anticancer research 2001;21(6A):4135-9.
2001: Colleoni M; Gelber S; Coates A S; Castiglione-Gertsch M; Gelber R D; Price K; Rudenstam C M; Lindtner J; Collins J; Thürlimann B; Holmberg S B; Cortes-Funes H; Simoncini E; Murray E; Fey M; Goldhirsch A;
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(21):4141-9.
2001: Biffi R; De Braud F; Orsi F; Pozzi S; Arnaldi P; Goldhirsch A; Rotmensz N; Robertson C; Bellomi M; Andreoni B
A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.
Cancer 2001;92(5):1204-12.
2001: Goldhirsch A; Glick J H; Gelber R D; Coates A S; Senn H J
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(18):3817-27.
2001: Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro M G; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
Anticancer research 2001;21(4B):3015-20.
2001: Cole B F; Gelber R D; Gelber S; Coates A S; Goldhirsch A
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.
Lancet 2001;358(9278):277-86.
2001: Mancuso P; Burlini A; Pruneri G; Goldhirsch A; Martinelli G; Bertolini F
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.
Blood 2001;97(11):3658-61.
2001: Curigliano G; Ferretti G; Colleoni M; Marrocco E; Peruzzotti G; De Cicco C; Paganelli G; Goldhirsch A
Bone scan had no role in the staging of 765 consecutive operable T(1-2)N(0-1) breast cancer patients without skeletal symptoms.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):724-5.
2001: Crivellari D; Pagani O; Veronesi A; Lombardi D; Nolè F; Thürlimann B; Hess D; Borner M; Bauer J; Martinelli G; Graffeo R; Sessa C; Goldhirsch A;
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):353-6.
2001: Gelber S; Coates A S; Goldhirsch A; Castiglione-Gertsch M; Marini G; Lindtner J; Edelmann D Z; Gudgeon A; Harvey V; Gelber R D;
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1671-5.
2001: De Pas T; de Braud F; Mandalà M; Curigliano G; Catania C; Ferretti G; Sozzi P; Solli P; Goldhirsch A
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine.
Lung cancer (Amsterdam, Netherlands) 2001;31(2-3):267-70.
2001: Nolè F; Munzone E; Mandalà M; Catania C; Orlando L; Zampino M G; Minchella I; Colleoni M; Peruzzotti G; Marrocco E; Goldhirsch A
Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):95-100.
2001: Kitchen P R; Smith T H; Henderson M A; Goldhirsch A; Castiglione-Gertsch M; Coates A S; Gusterson B; Brown R W; Gelber R D; Collins J P
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy.
ANZ journal of surgery 2001;71(1):27-31.
2001: Goldhirsch A; Gelber R D; Yothers G; Gray R J; Green S; Bryant J; Gelber S; Castiglione-Gertsch M; Coates A S
Adjuvant therapy for very young women with breast cancer: need for tailored treatments.
Journal of the National Cancer Institute. Monographs 2001;(30):44-51.
2000: Colleoni M; O'Neill A; Goldhirsch A; Gelber R D; Bonetti M; Thürlimann B; Price K N; Castiglione-Gertsch M; Coates A S; Lindtner J; Collins J; Senn H J; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Rudenstam C M
Identifying breast cancer patients at high risk for bone metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(23):3925-35.
2000: Coates A S; Hürny C; Peterson H F; Bernhard J; Castiglione-Gertsch M; Gelber R D; Goldhirsch A
Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3768-74.
2000: Colleoni M; Minchella I; Mazzarol G; Nolè F; Peruzzotti G; Rocca A; Viale G; Orlando L; Ferretti G; Curigliano G; Veronesi P; Intra M; Goldhirsch A
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1057-9.
2000: Pagani O; Sessa C; Nolè F; Crivellari D; Lombardi D; Thürlimann B; Hess D; Borner M; Bauer J; Martinelli G; Graffeo R; Zucchetti M; D'Incalci M; Goldhirsch A
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):985-91.
2000: De Pas T; de Braud F; Danesi R; Sessa C; Catania C; Curigliano G; Fogli S; del Tacca M; Zampino G; Sbanotto A; Rocca A; Cinieri S; Marrocco E; Milani A; Goldhirsch A
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):821-7.
2000: Veronesi U; Costa A; Zurrida S; Goldhirsch A; Colleoni M; Cinieri S; Marsiglia H; Gelber S; Castiglione-Gertsh M; Jellins J; Cataliotti L; Sacchini V; Kurtz J; Dixon J M; Orvieto E; Braun S; Siena S;
Breast cancer at the end of a successful century: meeting highlights from the First Milan Breast Cancer Conference and discussion paper for the Second Conference (Milan, 14-16 June, 2000).
Breast (Edinburgh, Scotland) 2000;9(3):161-70.
2000: Colleoni M; Orlando L; Nole' F; Goldhirsch A;
Introducing taxanes in the adjuvant treatment of breast cancer: expectations and reality.
Breast (Edinburgh, Scotland) 2000;9(3):134-8.
2000: Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò M G; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone P L; Pagliari G; de Braud F; Fazio N; Goldhirsch A
Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2393-400.
2000: Aebi S; Gelber S; Castiglione-Gertsch M; Gelber R D; Collins J; Thürlimann B; Rudenstam C M; Lindtner J; Crivellari D; Cortes-Funes H; Simoncini E; Werner I D; Coates A S; Goldhirsch A
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Lancet 2000;355(9218):1869-74.
2000: Munzone E; Nolé F; Orlando L; Mandalá M; Biffi R; Ciano C; Villa G; Civelli M; Goldhirsch A
Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients.
Journal of the National Cancer Institute 2000;92(9):755.
2000: Crivellari D; Bonetti M; Castiglione-Gertsch M; Gelber R D; Rudenstam C M; Thürlimann B; Price K N; Coates A S; Hürny C; Bernhard J; Lindtner J; Collins J; Senn H J; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Goldhirsch A
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1412-22.
2000: Roth A D; Maibach R; Martinelli G; Fazio N; Aapro M S; Pagani O; Morant R; Borner M M; Herrmann R; Honegger H; Cavalli F; Alberto P; Castiglione M; Goldhirsch A
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):301-6.
2000: Sabbioni M E; Siegrist H P; Bacchi M; Bernhard J; Castiglione M; Thürlimann B; Bonnefoi H; Perey L; Herrmann R; Goldhirsch A; Hürny C
Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment.
Breast cancer research and treatment 2000;59(3):279-87.
2000: Colleoni M; Bonetti M; Coates A S; Castiglione-Gertsch M; Gelber R D; Price K; Rudenstam C M; Lindtner J; Collins J; Thürlimann B; Holmberg S; Veronesi A; Marini G; Goldhirsch A
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):584-90.
2000: Orlando L; Colleoni M; Nolè F; Biffi R; Rocca A; Curigliano G; Ferretti G; Peruzzotti G; de Braud F; Masci G; Goldhirsch A
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):117-8.
2000: Graffeo R; Pagani O; Crivelli M; Zappa F; Borella P; Reiner M; Goldhirsch A
Parathyroid hormone-related protein in metastatic breast cancer induced hypercalcemia: a case report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):97-100.
1999: Locatelli M; Colleoni M; Noberasco C; Nolé F; Orlando L; Munzone E; Peruzzotti G; Goldhirsch A
Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1394-5.
1999: Brédart A; Didier F; Robertson C; Scaffidi E; Fonzo D; Costa A; Goldhirsch A; Autier P
Psychological distress in cancer patients attending the European Institute of Oncology in Milan.
Oncology 1999;57(4):297-302.
1999: Cote R J; Peterson H F; Chaiwun B; Gelber R D; Goldhirsch A; Castiglione-Gertsch M; Gusterson B; Neville A M
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.
Lancet 1999;354(9182):896-900.
1999: Nolè F; Minchella I; Colleoni M; Orvieto E; Munzone E; de Braud F; Peruzzotti G; Martinelli G; Zampino M G; Catania C; Pizzamiglio M; Veronesi P; Zurrida S; Galimberti V; Goldhirsch A; Veronesi U
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(8):993-6.
1999: Bertolini F; Paolucci M; Peccatori F; Cinieri S; Agazzi A; Ferrucci P F; Cocorocchio E; Goldhirsch A; Martinelli G
Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma.
British journal of haematology 1999;106(2):504-9.
1999: Bernhard J; Thürlimann B; Schmitz S F; Castiglione-Gertsch M; Cavalli F; Morant R; Fey M F; Bonnefoi H; Goldhirsch A; Hürny C
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1672-9.
1999: Bernhard J; Castiglione-Gertsch M; Schmitz S F; Thürlimann B; Cavalli F; Morant R; Fey M F; Bonnefoi H; Goldhirsch A; Hürny C
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK).
European journal of cancer (Oxford, England : 1990) 1999;35(6):913-20.
1999: Pagani O; Sessa C; Martinelli G; Crivellari D; Buonadonna A; Thürlimann B; Hess D; Borner M; Bauer J; Zampino G; Zimatore M; Graffeo R; Riva A; Goldhirsch A
Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):539-45.
1999: Sabbioni M E; Castiglione M; Hürny C; Siegrist H P; Bacchi M; Bernhard J; Thürlimann B; Bonnefoi H; Perey L; Goldhirsch A; Senn H J
Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999;7(3):149-53.
1999: Colleoni M; Orvieto E; Nolé F; Orlando L; Minchella I; Viale G; Peruzzotti G; Robertson C; Noberasco C; Galimberti V; Sacchini V; Veronesi P; Zurrida S; Orecchia R; Goldhirsch A
Prediction of response to primary chemotherapy for operable breast cancer.
European journal of cancer (Oxford, England : 1990) 1999;35(4):574-9.
1998: Goldhirsch A; Glick J H; Gelber R D; Senn H J
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
Journal of the National Cancer Institute 1998;90(21):1601-8.
1998: Colleoni M; Price K; Castiglione-Gertsch M; Goldhirsch A; Coates A; Lindtner J; Collins J; Gelber R D; Thürlimann B; Rudenstam C M
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1998;34(11):1693-700.
1998: Colleoni M; Orlando L; Robertson C; Nolé F; Peruzzotti G; Cassano R; Orvieto E; Viale G; Goldhirsch A
Assessment of response in primary chemotherapy for breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1140-1.
1998: Pinder S E; Murray S; Ellis I O; Trihia H; Elston C W; Gelber R D; Goldhirsch A; Lindtner J; Cortés-Funes H; Simoncini E; Byrne M J; Golouh R; Rudenstam C M; Castiglione-Gertsch M; Gusterson B A
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Cancer 1998;83(8):1529-39.
1998: Goldhirsch A; Coates A S; Castiglione-Gertsch M; Gelber R D
New treatments for breast cancer: breakthroughs for patient care or just steps in the right direction?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):973-6.
1998: Jungi W F; Bernhard J; Hürny C; Schmitz S F; Hanselmann S; Gusset H; Pestalozzi D; Goldhirsch A
Effect of carboplatin on response and palliation in hormone-refractory prostate cancer. Swiss Group for Clinical Cancer Research (SAKK).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(5):462-8.
1998: Bernhard J; Hürny C; Coates A S; Peterson H F; Castiglione-Gertsch M; Gelber R D; Galligioni E; Marini G; Thürlimann B; Forbes J F; Goldhirsch A; Senn H J; Rudenstam C M
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
British journal of cancer 1998;78(5):686-93.
1998: De Pas T; De Braud F; Orlando L; Nolè F; Munzone E; Zampino M G; Fazio N; Aapro M S; Goldhirsch A
High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(8):917-9.
1998: Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(7):767-73.
1998: Colleoni M; Martinelli G; Beretta F; Marone C; Gallino A; Fontana M; Graffeo R; Zampino G; De Pas T; Cipolla G; Martinoni C; Goldhirsch A
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2371-6.
1998: Borner M M; Castiglione M; Bacchi M; Weber W; Herrmann R; Fey M F; Pagani O; Leyvraz S; Morant R; Pestalozzi B; Hanselmann S; Goldhirsch A
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):535-41.
1998: Goldhirsch A; Colleoni M; Coates A S; Castiglione-Gertsch M; Gelber R D
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):489-93.
1998: Colleoni M; Nole F; Minchella I; Noberasco C; Luini A; Orecchia R; Veronesi P; Zurrida S; Viale G; Goldhirsch A;
Pre-operative chemotherapy and radiotherapy in breast cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(5):641-5.
1998: Pagani O; O'Neill A; Castiglione M; Gelber R D; Goldhirsch A; Rudenstam C M; Lindtner J; Collins J; Crivellari D; Coates A; Cavalli F; Thürlimann B; Simoncini E; Fey M; Price K; Senn H J
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
European journal of cancer (Oxford, England : 1990) 1998;34(5):632-40.
1998: Goldhirsch A; Coates A S; Colleoni M; Castiglione-Gertsch M; Gelber R D
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1358-62.
1998: Colleoni M; Coates A; Pagani O; Goldhirsch A
Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer: still a question?
Cancer treatment reviews 1998;24(1):15-26.
1998: Goldhirsch A; Glick J H; Gelber R D; Senn H J
International Consensus Panel on the treatment of primary breast cancer. V: Update 1998.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():481-97.
1998: Gelber R D; Bonetti M; Cole B F; Gelber S; Goldhirsch A
Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():373-89.
1997: Castiglione-Gertsch M; Tattersall M; Hacking A; Goldhirsch A; Gudgeon A; Gelber R D; Lindtner J; Coates A; Collins J; Isley M; Senn H J; Rudenstam C M
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2321-5.
1997: Sessa C; Pagani O; Martinelli G; Cerny T; de Jong J; Goldhirsch A; Zimatore M; Cavalli F
Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-52-S17-57.
1997: Nolè F; de Braud F; Aapro M; Minchella I; De Pas M; Zampino M G; Monti S; Andreoni G; Goldhirsch A
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(9):865-70.
1997: Bernhard J; Hürny C; Coates A S; Peterson H F; Castiglione-Gertsch M; Gelber R D; Goldhirsch A; Senn H J; Rudenstam C M
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(9):825-35.
1997: Goldhirsch A; Gelber R D; Castiglione M; O'Neill A; Thürlimann B; Rudenstam C M; Lindtner J; Collins J; Forbes J; Crivellari D; Coates A; Cavalli F; Simoncini E; Fey M F; Pagani O; Price K; Senn H J
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):751-6.
1997: Pagani O; Sessa C; Martinelli G; Cerny T; de Jong J; Goldhirsch A; Zimatore M; Cavalli F
Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):655-61.
1997: Thürlimann B; Castiglione M; Hsu-Schmitz S F; Cavalli F; Bonnefoi H; Fey M F; Morant R; Löhnert T; Goldhirsch A
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
European journal of cancer (Oxford, England : 1990) 1997;33(7):1017-24.
1997: Pestalozzi B C; Peterson H F; Gelber R D; Goldhirsch A; Gusterson B A; Trihia H; Lindtner J; Cortés-Funes H; Simmoncini E; Byrne M J; Golouh R; Rudenstam C M; Castiglione-Gertsch M; Allegra C J; Johnston P G
Prognostic importance of thymidylate synthase expression in early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1923-31.
1996: Goldhirsch A; Gelber R D
Endocrine therapies of breast cancer.
Seminars in oncology 1996;23(4):494-505.
1996: Gelber R D; Goldhirsch A; Cole B F; Wieand H S; Schroeder G; Krook J E
A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.
Journal of the National Cancer Institute 1996;88(15):1039-45.
1996: Thürlimann B; Beretta K; Bacchi M; Castiglione-Gertsch M; Goldhirsch A; Jungi W F; Cavalli F; Senn H J; Fey M; Löhnert T
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):471-9.
1996: Hürny C; Bernhard J; Coates A S; Castiglione-Gertsch M; Peterson H F; Gelber R D; Forbes J F; Rudenstam C M; Simoncini E; Crivellari D; Goldhirsch A; Senn H J
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
Lancet 1996;347(9011):1279-84.
1996: Marini G; Murray S; Goldhirsch A; Gelber R D; Castiglione-Gertsch M; Price K N; Tattersall M H; Rudenstam C M; Collins J; Lindtner J; Cavalli F; Cortés-Funes H; Gudgeon A; Forbes J F; Galligioni E; Coates A S; Senn H J
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):245-50.
1996: Hürny C; Bernhard J; Coates A; Peterson H F; Castiglione-Gertsch M; Gelber R D; Rudenstam C M; Collins J; Lindtner J; Goldhirsch A; Senn H J
Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.
Medical care 1996;34(3):234-48.
1996: Buser K; Bacchi M; Goldhirsch A; Greiner R; Diener P; Sessa C; Jungi W F; Forni M; Leyvraz S; Engeler V
Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):65-70.
1996: Goldhirsch A; Wood W C; Senn H J; Glick J H; Gelber R D
IX. International consensus conference on primary treatment of breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():325-35.
1996: Castiglione-Gertsch M; Gelber R D; Goldhirsch A
Adjuvant systemic therapy: the issues of timing and sequence.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():201-13.
1995: Crivellari D; Price K N; Hagen M; Goldhirsch A; Gelber R D; Castiglione M; Coates A S; Rudenstam C M; Collins J; Lindtner J
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(8):769-76.
1995: Goldhirsch A; Wood W C; Senn H J; Glick J H; Gelber R D
Meeting highlights: international consensus panel on the treatment of primary breast cancer.
Journal of the National Cancer Institute 1995;87(19):1441-5.
1995: Gelber R D; Cole B F; Goldhirsch A; Bonadonna G; Howell A; McArdle C S; Mouridsen H T; Rubens R D; Welvaart K
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival.
The cancer journal from Scientific American 1995;1(2):114-21.
1995: Goldhirsch A; Gelber R D; Castiglione M; Price K N; Rudenstam C M; Lindtner J; Collins J; Senn H J; Cavalli F; Galligioni E
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group.
Israel journal of medical sciences 1995;31(2-3):144-54.
1994: Borner M; Bacchi M; Goldhirsch A; Greiner R; Harder F; Castiglione M; Jungi W F; Thürlimann B; Cavalli F; Obrecht J P
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(10):2071-7.
1994: Castiglione-Gertsch M; Johnsen C; Goldhirsch A; Gelber R D; Rudenstam C M; Collins J; Lindtner J; Hacking A; Cortes-Funes H; Forbes J
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):717-24.
1994: Goldhirsch A; Gelber R D; Castiglione M; Price K N; Rudenstam C M; Lindtner J; Collins J; Senn H J; Brunner K W; Galligioni E
Present and future projects of the International Breast Cancer Study Group.
Cancer 1994;74(3 Suppl):1139-49.
1994: Lenderking W R; Gelber R D; Cotton D J; Cole B F; Goldhirsch A; Volberding P A; Testa M A
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.
The New England journal of medicine 1994;330(11):738-43.
1994: Goldhirsch A; Gelber R D; Price K N; Castiglione M; Coates A S; Rudenstam C M; Collins J; Lindtner J; Hacking A; Marini G
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Lancet 1994;343(8894):377-81.
1994: Hürny C; Bernhard J; Coates A; Castiglione M; Peterson H F; Gelber R D; Rudenstam C M; Goldhirsch A; Senn H J
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(1):65-74.
1993: Gelber R D; Goldhirsch A; Cole B F
Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International Breast Cancer Study Group.
Controlled clinical trials 1993;14(6):485-99.
1993: Castiglione-Gertsch M; Pampallona S; Varini M; Cavalli F; Brunner K; Senn H J; Goldhirsch A; Metzger U
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):735-40.
1993: Hürny C; Bernhard J; Bacchi M; van Wegberg B; Tomamichel M; Spek U; Coates A; Castiglione M; Goldhirsch A; Senn H J
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(4):200-8.
1993: Gelber R D; Goldhirsch A; Coates A S
Adjuvant therapy for breast cancer: understanding the overview. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):580-5.
1993: Gelber R D; Goldhirsch A; Cole B F
Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group.
Cancer treatment reviews 1993;19 Suppl A():73-84.
1992: Spataro V; Price K; Goldhirsch A; Cavalli F; Simoncini E; Castiglione M; Rudenstam C M; Collins J; Lindtner J; Gelber R D
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):733-40.
1992: Gusterson B A; Gelber R D; Goldhirsch A; Price K N; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam C M; Golouh R; Reed R
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1049-56.
1992: Gelber R D; Lenderking W R; Cotton D J; Cole B F; Fischl M A; Goldhirsch A; Testa M A
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group.
Annals of internal medicine 1992;116(12 Pt 1):961-6.
1992: Hürny C; Bernhard J; Gelber R D; Coates A; Castiglione M; Isley M; Dreher D; Peterson H; Goldhirsch A; Senn H J
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1992;28(1):118-24.
1991: Gelber R D; Goldhirsch A; Cavalli F
Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.
Annals of internal medicine 1991;114(8):621-8.
1991: Sessa C; Goldhirsch A; Martinelli G; Alerci M; Imburgia L; Cavalli F
Phase I study of the combination of monthly carboplatin and weekly cisplatin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(2):123-9.
1990: Richner J; Gerber H A; Locher G W; Goldhirsch A; Gelber R D; Gullick W J; Berger M S; Groner B; Hynes N E
c-erbB-2 protein expression in node negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(4):263-8.
1989: Goldhirsch A; Gelber R D
Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():43-53.
1989: Gelber R D; Goldhirsch A
Methods for assessing treatment efficacy in trials for adjuvant therapy for breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():211-9.
1989: Goldhirsch A; Gelber R D
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():153-62.
1988: Goldhirsch A; Greiner R; Dreher E; Sessa C; Krauer F; Forni M; Jungi F W; Brunner K W; Veraguth P; Engeler V
Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy.
Cancer 1988;62(1):40-7.
1988: Goldhirsch A; Berger E; Müller O; Maibach R; Misteli S; Buser K; Roesler H; Brunner K
Ovarian cancer and tumor markers: sialic acid, galactosyltransferase and CA-125.
Oncology 1988;45(4):281-6.
1986: Davis B W; Gelber R D; Goldhirsch A; Hartmann W H; Locher G W; Reed R; Golouh R; Säve-Söderbergh J; Holloway L; Russell I
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis.
Cancer 1986;58(12):2662-70.
1986: Pedrazzini A; Gelber R; Isley M; Castiglione M; Goldhirsch A
First repeated bone scan in the observation of patients with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(3):389-94.
1985: Goldhirsch A; Greiner R; Dreher E; Locher G; Davis B W; Reinhard J P; Joss R; Brunner K W
The treatment of ovarian cancer by a multimodality approach: remission induction with chemotherapy--hexa PAMP and PAMP regimens--followed by whole-abdominal radiation.
Onkologie 1985;8(6):383-7.
1985: Greiner R; Goldhirsch A; Dreher E; Locher G; Jeanneret C; Meister A; Mihic N; Veraguth P
[Total abdominal irradiation following combination chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancer]
Onkologie 1985;8(6):364-72.
1984: Davis B W; Berger E G; Locher G W; Zeller M; Goldhirsch A
Immunohistochemical localization of galactosyltransferase in the normal human ovary and fallopian tube.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1984;32(1):92-6.
1984: Greiner R; Goldhirsch A; Davis B W; Dreher E; Peyer T; Locher G; Neuenschwander H; Joss R; Brunner K; Veraguth P
Whole-abdomen radiation in patients with advanced ovarian carcinoma after surgery, chemotherapy, and second-look laparotomy.
Journal of cancer research and clinical oncology 1984;107(2):94-8.
1984: Davis B W; Goldhirsch A; Locher G W; Dreher E; Greiner R; Burki K; Brunner K W
Pathologic data of prognostic significance for remission induction in advanced ovarian carcinoma.
Journal of cancer research and clinical oncology 1984;107(2):106-10.
1983: Dreher E; Goldhirsch A; Greiner R; Herrmann U; Locher G
[New therapeutic concept for advanced ovarian cancer (FIGO IIb+c, III, IV)]
Gynäkologische Rundschau 1983;22 Suppl 3():89-94.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Aron Goldhirsch

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Aron Goldhirsch (preview)

All Publications